Loading...
•
Dec 31, 2022
Enovis Q4 2022 Earnings Report
Enovis reported a slight increase in Q4 sales, driven by strong growth in the Reconstructive segment, but experienced a net loss from continuing operations.
Key Takeaways
Enovis reported a 2% increase in fourth-quarter sales to $409 million, with 5% organic growth. The Reconstructive segment grew 12%. The company reported a net loss from continuing operations of $55 million, or $0.71 per diluted share, and adjusted earnings per share of $0.72.
Q4 sales grew 2% to $409 million with 5% organic growth.
Reconstructive segment sales increased by 12% (14% organic).
Prevention and Recovery segment sales declined 2% with 1% organic growth.
Reported a net loss of $0.71 per diluted share, with adjusted EPS of $0.72.
Enovis
Enovis
Forward Guidance
Enovis anticipates organic revenue growth of 5-6% and adjusted EPS in the range of $2.15 to $2.30 for 2023.
Positive Outlook
- Revenue is expected to organically grow 5-6% from the prior year
- Adjusted EBITDA of $255 to $265 million
- Adjusted earnings per diluted share in the range of $2.15 to $2.30